WO2000025743A3 - Improved growth stimulant compositions - Google Patents

Improved growth stimulant compositions Download PDF

Info

Publication number
WO2000025743A3
WO2000025743A3 PCT/US1999/023993 US9923993W WO0025743A3 WO 2000025743 A3 WO2000025743 A3 WO 2000025743A3 US 9923993 W US9923993 W US 9923993W WO 0025743 A3 WO0025743 A3 WO 0025743A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth stimulant
improved growth
release
stimulant compositions
improved
Prior art date
Application number
PCT/US1999/023993
Other languages
French (fr)
Other versions
WO2000025743A2 (en
Inventor
Chung Shih
Thomas J Kennedy
Peter James Knight
Daniel S Robins
Zezhi Jesse Shao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to BRPI9914996-6 priority Critical patent/BRPI9914996B8/en
Priority to BR9914996-6A priority patent/BR9914996A/en
Priority to CA002348841A priority patent/CA2348841C/en
Priority to AU30967/00A priority patent/AU777393B2/en
Publication of WO2000025743A2 publication Critical patent/WO2000025743A2/en
Publication of WO2000025743A3 publication Critical patent/WO2000025743A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.
PCT/US1999/023993 1998-11-04 1999-11-02 Improved growth stimulant compositions WO2000025743A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI9914996-6 BRPI9914996B8 (en) 1998-11-04 1999-11-02 Anabolic implant composition and process to stimulate increased growth rate, greater amount of growth and greater feed efficiency in an animal.
BR9914996-6A BR9914996A (en) 1998-11-04 1999-11-02 Stimulating compositions for improved growth
CA002348841A CA2348841C (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions
AU30967/00A AU777393B2 (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04
US09/185,944 1998-11-04

Publications (2)

Publication Number Publication Date
WO2000025743A2 WO2000025743A2 (en) 2000-05-11
WO2000025743A3 true WO2000025743A3 (en) 2000-08-24

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/023993 WO2000025743A2 (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BRPI9914996B8 (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
ES2948624T3 (en) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Improved process for the preparation of trenbolone and/or trenbolone acetate
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167662A (en) * 1984-11-22 1986-06-04 Crb Virbac Sarl Sustained release devices
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167662A (en) * 1984-11-22 1986-06-04 Crb Virbac Sarl Sustained release devices
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
O'CALLAGHAN, D. ET AL: "Effects of long acting and short acting estradiol implants on growth rate and carcass weight of steers", VET. REC. (1986), 119(17), 427-9, XP000907270 *

Also Published As

Publication number Publication date
BR9914996A (en) 2001-07-10
TWI250027B (en) 2006-03-01
CO5140100A1 (en) 2002-03-22
AU777393B2 (en) 2004-10-14
BRPI9914996A (en) 2001-07-10
ZA200103494B (en) 2002-07-30
WO2000025743A2 (en) 2000-05-11
CR6351A (en) 2003-11-20
CA2348841A1 (en) 2000-05-11
BRPI9914996B1 (en) 2011-11-01
CA2348841C (en) 2007-04-17
PE20001092A1 (en) 2000-10-31
AR025133A1 (en) 2002-11-13
BRPI9914996B8 (en) 2021-07-06
AU3096700A (en) 2000-05-22
MY134868A (en) 2007-12-31

Similar Documents

Publication Publication Date Title
BR0013116B1 (en) Single dose oral formulations to control ectoparasite infestation in pets, and their use.
TR28853A (en) A preparation for controlled delivery of active ingredients which are suitable for therapeutic or rearing animals to improve development and to evaluate feed.
WO2000025743A3 (en) Improved growth stimulant compositions
BR9106676A (en) PEPTIDE, PROCESS TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMAL, PHARMACEUTICAL COMPOSITION TO PROMOTE THE RELEASE OF GROWTH HORMONE LEVELS IN ANIMALS, USE OF THE COMPOUND AND PROCESS TO PROMOTE THE LIBERATION IN THE ELEVATION BLOOD
US20010041697A1 (en) Implant composition containing melengestrol acetate and trenbolone acetate
BR0014610B1 (en) compositions comprising a synergistic mixture of active compounds having insecticidal and acaricidal properties, use of said mixture, and processes for controlling animal pests and pesticide preparation.
EP1510214A3 (en) 8a-azalides as veterinary antimicrobial agents
AU4519189A (en) Medicaments for the treatment of toxoplasmosis
TH48412A3 (en) Growth stimulant composition That has been updated
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
HU9201295D0 (en) Medical preparations for treating cryptosporidiosys
EP1177785A3 (en) Growth promoting pharmaceutical implant
ECSP993205A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948)
WO2002038103A3 (en) Probiotic compositions and methods against bacterial infection in livestock animals
MXPA99005235A (en) Oral veterinary fluoroquinolone antibacterial composition for extended duration of therapy and method of treating.
IT1209426B (en) Controlled release antimicrobial compsn. for animals
EP1779853A3 (en) 9a-azalides as veterinary antimicrobial agents
BR9612813A (en) Antibacterial composition of oral veterinary fluoroquinolone for prolonged duration of therapy and method of treatment
TH34831A (en) Preventive and therapeutic agents for infectious diseases of fish. And shellfish
WO1997037631A3 (en) Chemotherapeutic veterinary drug containing oxytetracycline, sulfadimidine and neomycin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 30967/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2348841

Country of ref document: CA

Ref country code: CA

Ref document number: 2348841

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 200103494

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/004483

Country of ref document: MX

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: 30967/00

Country of ref document: AU